@article{article, title  = {{IUC26698-96 Durvalumab + BCG therapy in BCG-naïve, high-risk NMIBC: efficacy and safety analyses from POTOMAC}},

 publisher = {{Oxford University Press (OUP)}},

 url = {{https://doi.org/10.1093/oncolo/oyag286.009 }},

 year = {{2026}},

 month = {{8}},

 author = {{Hussain S and Shore N and Nishiyama H and Palou Redorta J and Krawczynski M and Seyitkuliev A and Guerrero-Ramos F and Kato M and Powles T and De Santis M}},

 doi = {{10.1093/oncolo/oyag286.009}},

 volume = {{31}},

 journal = {{The Oncologist}},

 issue = {{Supplement_2}},

 note = {{Accessed on 2026/10/16}}}